Jefferies Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $40

Benzinga · 2d ago
Jefferies analyst Faisal Khurshid initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $40.